Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion type Assertion NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_head.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion wasGeneratedBy ECO_0000203 NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_provenance.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion wasDerivedFrom befree-20140225 NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_provenance.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion SIO_000772 16812949 NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_provenance.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion evidence source_evidence_literature NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_provenance.
- NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_assertion description "[We evaluated whether cytochrome P450 (CYP) poor metabolizer polymorphisms of CYP2D6 and CYP2C19 are relevant for the outcome (measured by length of hospitalization) during treatment with psychotropic medications in patients with depression or schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675962.RAt9lFP5l75DO4yRJ_S6jlBjfEkO33KN044FVUWDo1zCM130_provenance.